| Photodynamic therapy of high grade glioma–long term survival SS Stylli, AH Kaye, L MacGregor, M Howes, P Rajendra Journal of clinical neuroscience 12 (4), 389-398, 2005 | 264 | 2005 |
| Invadopodia: at the cutting edge of tumour invasion SS Stylli, AH Kaye, P Lock Journal of clinical neuroscience 15 (7), 725-737, 2008 | 256 | 2008 |
| Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. JS Hill, SB Kahl, AH Kaye, SS Stylli, MS Koo, MF Gonzales, NJ Vardaxis, ... Proceedings of the National Academy of Sciences 89 (5), 1785-1789, 1992 | 185 | 1992 |
| Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation SS Stylli, STT I, AM Verhagen, SS Xu, I Pass, SA Courtneidge, P Lock Journal of cell science 122 (15), 2727-2740, 2009 | 167 | 2009 |
| Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies FH Tan, TL Putoczki, SS Stylli, RB Luwor OncoTargets and therapy, 635-645, 2019 | 160 | 2019 |
| Optical coherence tomography predicts visual outcome for pituitary tumors HV Danesh-Meyer, A Wong, T Papchenko, K Matheos, S Stylli, A Nichols, ... Journal of Clinical Neuroscience 22 (7), 1098-1104, 2015 | 152 | 2015 |
| The role of Stat3 in glioblastoma multiforme RB Luwor, SS Stylli, AH Kaye Journal of clinical neuroscience 20 (7), 907-911, 2013 | 140 | 2013 |
| The emergent role of exosomes in glioma J Gourlay, AP Morokoff, RB Luwor, HJ Zhu, AH Kaye, SS Stylli Journal of Clinical Neuroscience 35, 13-23, 2017 | 137 | 2017 |
| Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin MA Rosenthal, B Kavar, JS Hill, DJ Morgan, RL Nation, SS Stylli, ... Journal of clinical oncology 19 (2), 519-524, 2001 | 123 | 2001 |
| Visual acuity and pattern of visual field loss at presentation in pituitary adenoma S Ogra, AD Nichols, S Stylli, AH Kaye, PJ Savino, HV Danesh-Meyer Journal of Clinical Neuroscience 21 (5), 735-740, 2014 | 120 | 2014 |
| Photodynamic therapy of cerebral glioma–A review Part II–Clinical studies SS Stylli, AH Kaye Journal of Clinical Neuroscience 13 (7), 709-717, 2006 | 119 | 2006 |
| Mouse models of glioma SS Stylli, RB Luwor, TMB Ware, F Tan, AH Kaye Journal of Clinical Neuroscience 22 (4), 619-626, 2015 | 106 | 2015 |
| Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome SS Stylli, M Howes, L MacGregor, P Rajendra, AH Kaye Journal of Clinical Neuroscience 11 (6), 584-596, 2004 | 106 | 2004 |
| Selective uptake of hematoporphyrin derivative into human cerebral glioma JS Hill, AH Kaye, WH Sawyer, G Morstyn, PD Megison, SS Stylli Neurosurgery 26 (2), 248-254, 1990 | 106 | 1990 |
| Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells U Novak, SS Stylli, AH Kaye, G Lepperdingerm Cancer research 59 (24), 6246-6250, 1999 | 102 | 1999 |
| Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. JS Hill, SB Kahl, SS Stylli, Y Nakamura, MS Koo, AH Kaye Proceedings of the National Academy of Sciences 92 (26), 12126-12130, 1995 | 94 | 1995 |
| The role of interleukin‑6‑STAT3 signalling in glioblastoma AJ West, V Tsui, SS Stylli, H Nguyen, AP Morokoff, AH Kaye, RB Luwor Oncology letters 16 (4), 4095-4104, 2018 | 91 | 2018 |
| Photodynamic therapy of cerebral glioma–a review Part I–a biological basis SS Stylli, AH Kaye Journal of Clinical Neuroscience 13 (6), 615-625, 2006 | 88 | 2006 |
| The role of STAT3 signaling in mediating tumor resistance to cancer therapy F H Tan, T L Putoczki, S S Stylli, R B Luwor Current Drug Targets 15 (14), 1341-1353, 2014 | 76 | 2014 |
| Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy KW Woodburn, S Stylli, JS Hill, AH Kaye, JA Reiss, DR Phillips British journal of cancer 65 (3), 321-328, 1992 | 75 | 1992 |
A/Prof Andrew MorokoffNeurosurgeon, University of Melbourne, Royal Melbourne HospitalBestätigte E-Mail-Adresse bei unimelb.edu.au
